Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor Ganti(University of Nebraska Medical Center), Miranda Hughes(National Comprehensive Cancer Network), Robert J. Downey(Memorial Sloan Kettering Cancer Center), Collin M. Blakely(City College of San Francisco), Marianna Koczywas(City Of Hope National Medical Center), Billy W. Loo(Princess Margaret Cancer Centre), Wade T. Iams(Vanderbilt University Medical Center), Angel Qin(University of Michigan), J.C. Grecula(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Charles Florsheim, Puneeth Iyengar(Memorial Sloan Kettering Cancer Center), Anne C. Chiang(Smilow Cancer Hospital), Jonathan W. Goldman(University of California, Los Angeles), Afshin Dowlati(University Hospitals of Cleveland), Michael Shafique(Moffitt Cancer Center), Julian R. Molina, Kathryn A. Gold(University of California San Diego), Christopher D’Avella(University of Pennsylvania), Jacob Sands(Harvard University), Sonam Puri(University of Utah), Christine L. Hann(Johns Hopkins University), Martin J. Edelman(Fox Chase Cancer Center), Nisha Mohindra(Fox Chase Cancer Center), M. Bassetti(University of Wisconsin–Madison), Maya Khalil(University of Colorado Cancer Center), Karen Kelly(Cancer Research Center), Saiama N. Waqar(Washington University in St. Louis), Chad G. Rusthoven(University of Colorado Cancer Center), Rafael Santana-Dávila(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Thomas A. D’Amico(General Marble (Greece)), Kristina M. Gregory(National Comprehensive Cancer Network), César A. Moran(The University of Texas MD Anderson Cancer Center), Saraswati Pokharel(Roswell Park Comprehensive Cancer Center), Robert E. Merritt(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 459
Related Papers
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766